PUBLISHER: The Business Research Company | PRODUCT CODE: 2127197
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127197
Anti-reflux infant formula is a specialized baby formula developed to minimize frequent spit-up and regurgitation in infants by increasing milk thickness and improving its ability to remain in the stomach. It is generally recommended for infants experiencing gastroesophageal reflux (GER) and should be used under medical guidance.
The primary product types of anti-reflux infant formula include thickened formula, pre-thickened formula, and specialty formula. Thickened formula refers to infant nutrition products formulated with added thickening agents to help reduce regurgitation and reflux symptoms in infants. These products are developed using ingredients such as cow milk-based, soy-based, protein hydrolysate-based, and other ingredients and are designed for age groups including zero to six months, six to twelve months, and twelve to twenty-four months. They are distributed through supermarkets or hypermarkets, pharmacies or drug stores, online stores, specialty stores, and others and are used by end users including hospitals and neonatal intensive care units, homecare settings, and pediatric clinics.
Tariffs are influencing the anti-reflux infant formula market by increasing the cost of imported dairy ingredients, specialty proteins, starch additives, packaging materials, and infant nutrition manufacturing inputs. This is creating pricing pressure and supply chain disruptions, affecting product availability and increasing production costs across infant nutrition categories. Product segments such as specialty formulas, protein hydrolysate-based formulas, and pre-thickened formulations are most affected, particularly in import-dependent regions such as Asia-Pacific and Europe. However, tariffs are also encouraging domestic production expansion, regional supplier diversification, and increased investment in local infant nutrition manufacturing capabilities, creating stronger long-term market resilience.
The anti-reflux infant formula market research report is one of a series of new reports from The Business Research Company that provides anti-reflux infant formula market statistics, including anti-reflux infant formula industry global market size, regional shares, competitors with a anti-reflux infant formula market share, detailed anti-reflux infant formula market segments, market trends and opportunities, and any further data you may need to thrive in the anti-reflux infant formula industry. This anti-reflux infant formula market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The anti-reflux infant formula market size has grown strongly in recent years. It will grow from $74.24 billion in 2025 to $81.58 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of infant gastroesophageal reflux cases, increasing awareness regarding infant digestive disorders, growth in infant nutrition product adoption, increasing recommendations from pediatric healthcare professionals, rising demand for specialty infant formulas.
The anti-reflux infant formula market size is expected to see strong growth in the next few years. It will grow to $117.14 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing development of clinically advanced infant formulas, rising demand for customized nutritional solutions, growing focus on infant gut health management, expansion of premium pediatric nutrition products, increasing investment in specialized infant healthcare products. Major trends in the forecast period include increasing demand for clinically formulated anti-reflux nutrition products, rising preference for hydrolyzed and easy-to-digest ingredients, growing use of specialty formulas for infant digestive health management, increasing adoption of medically supervised infant nutrition solutions, expansion of allergy-specific and reflux-focused infant formulations.
The increasing number of infants is expected to drive the growth of the anti-reflux infant formula market going forward. An infant refers to a child from birth to approximately one year of age who relies on caregivers for essential needs and early development. The infant population is growing due to rising birth rates supported by improved healthcare access and enhanced living conditions. Anti-reflux infant formula helps infants by improving feed retention, reducing regurgitation, and supporting better nutrient absorption. For instance, in July 2025, according to the Office for National Statistics Census, a UK-based government agency, England and Wales recorded 594,677 live births in 2024, representing an increase of 3,605 births (0.6%) compared with 591,072 live births in 2023. Therefore, the increasing number of infants is driving the growth of the anti-reflux infant formula market.
The growing number of working mothers is expected to drive the growth of the anti-reflux infant formula market going forward. Working mothers are women with children who participate in paid employment while managing both childcare and professional responsibilities. The number of working mothers is increasing primarily due to rising living expenses, which encourage households to rely on dual incomes to meet financial requirements. Anti-reflux infant formula assists working mothers by minimizing infants' spit-up and feeding-related discomfort, making feeding routines more manageable and consistent during demanding work schedules. For instance, in April 2024, according to the Bureau of Labor Statistics, a US-based government agency, 74% of mothers with children under the age of 18 were part of the workforce in 2023, reflecting a 1.1 percentage point increase from the previous year. Therefore, the growing number of working mothers is driving the growth of the anti-reflux infant formula market.
The increase in household incomes is expected to drive the growth of the anti-reflux infant formula market going forward. Household income refers to the total earnings received by all members of a household from various sources over a specific period, typically one year. Household incomes are increasing mainly due to expanding employment opportunities and wage growth, as industrial development and demand for skilled workers enable more individuals to earn higher salaries and additional income streams. Rising household incomes encourage the adoption of anti-reflux infant formula as families have greater purchasing power to invest in specialized and premium infant nutrition products, which are generally more costly than standard formulas, helping manage infant feeding challenges such as reflux. For instance, in October 2024, according to Statistics Iceland, an Iceland-based government agency, household disposable income increased by 6.6% in the second quarter of 2024 compared with the same period in the previous year. Therefore, increasing household incomes are driving the growth of the anti-reflux infant formula market.
Major companies operating in the anti-reflux infant formula market report are Humana GmbH, Nestle SA, Abbott Laboratories, Danone SA, Reckitt Benckiser Group plc, Royal FrieslandCampina NV, Perrigo Company plc, The Hain Celestial Group Inc, Hero Group AG, HiPP GmbH & Co Vertrieb KG, Richen Nutritional Technology Co Ltd, Kendal Nutricare Ltd, Laboratorios Ordesa SL, Geo-Poland Sp z oo, Fasska Sp z oo, Lactalis Nutrition Sante SAS, Medical Brands Innovations BV, Laboratorios Basi, Sanulac Nutritionals BV, Bellamy's Organic, Bubs Australia, Nannycare
North America was the dominating region in the anti-reflux infant formula market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the anti-reflux infant formula market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the anti-reflux infant formula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The anti-reflux infant formula market consists of sales of rice starch-based anti-reflux formula, carob bean gum-based anti-reflux formula, and extensively hydrolyzed anti-reflux formula. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anti-Reflux Infant Formula Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses anti-reflux infant formula market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for anti-reflux infant formula ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anti-reflux infant formula market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.